Bhupal Ban

Bhupal Ban, Ph.D., serves as the Associate Director of Antibody Discovery, Engineering, and Development at Crossbow Therapeutics, Inc., since August 2022. With extensive experience in the biotechnology sector, Bhupal Ban has led efforts in antibody discovery and engineering, including pMHC antigen preparation for T-cell mimic platforms and targeting intracellular cancer in bispecific formats. Previous roles include Senior Scientist positions at Entrada Therapeutics and Indiana Biosciences Research Institute, where contributions focused on antibody engineering and discovery against cytosolic targets employing high-throughput technologies. Bhupal Ban's academic background includes a Ph.D. in Biochemistry and Molecular Biology from Tulane University School of Medicine and a Master's in Organic Chemistry from Tribhuvan University.